Your browser doesn't support javascript.
loading
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Czuczman, Myron S; Trnený, Marek; Davies, Andrew; Rule, Simon; Linton, Kim M; Wagner-Johnston, Nina; Gascoyne, Randy D; Slack, Graham W; Brousset, Pierre; Eberhard, David A; Hernandez-Ilizaliturri, Francisco J; Salles, Gilles; Witzig, Thomas E; Zinzani, Pier Luigi; Wright, George W; Staudt, Louis M; Yang, Yandan; Williams, P Mickey; Lih, Chih-Jian; Russo, Jacqueline; Thakurta, Anjan; Hagner, Patrick; Fustier, Pierre; Song, Dale; Lewis, Ian D.
Afiliação
  • Czuczman MS; Roswell Park Cancer Institute, Buffalo, New York. mczuczman@celgene.com.
  • Trnený M; Department of Hematology, Charles University Hospital, Prague, Czech Republic.
  • Davies A; Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Rule S; Department of Haematology, Derriford Hospital, Plymouth, United Kingdom.
  • Linton KM; Division of Molecular and Clinical Cancer Sciences, The Christie Foundation Trust, Manchester, United Kingdom.
  • Wagner-Johnston N; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Gascoyne RD; Centre for Lymphoid Cancers, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Slack GW; Centre for Lymphoid Cancers, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Brousset P; Laboratoire D'Anatomie Pathologique, Centre Hospitalier Universitaire Purpan, Toulouse, France.
  • Eberhard DA; Department of Pathology/Laboratory Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
  • Hernandez-Ilizaliturri FJ; Roswell Park Cancer Institute, Buffalo, New York.
  • Salles G; Hematology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Benite, France.
  • Witzig TE; Departments of Laboratory Medicine and Pathology and Hematology, Mayo Clinic, Rochester, Minnesota.
  • Zinzani PL; Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy.
  • Wright GW; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yang Y; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.
  • Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc. and Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Russo J; Celgene Corporation, Summit, New Jersey.
  • Thakurta A; Celgene Corporation, Summit, New Jersey.
  • Hagner P; Celgene Corporation, Summit, New Jersey.
  • Fustier P; Celgene Corporation, Boudry, Switzerland.
  • Song D; Celgene Corporation, Summit, New Jersey.
  • Lewis ID; Divison of Haematology, Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia.
Clin Cancer Res ; 23(15): 4127-4137, 2017 Aug 01.
Article em En | MEDLINE | ID: mdl-28381416
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Talidomida / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Talidomida / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article